Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,369 total articles
Amneal's move into metered-dose inhalation products, a progressing biosimilar program, and improving free cash flow create a favorable risk/reward from current levels. We recommend a tactical long with a mid-term horizon to capture commercial ramp and clinical readouts while respecting operational and regulatory risks.
Columbia Seligman Premium Technology Growth Fund (STK) is a tech-focused covered-call closed-end fund that currently yields ~4.0%, trades at a low earnings multiple, and shows strong technical momentum. For investors who want tech exposure with income and a measure of downside cushioning, STK offers a more balanced path than a straight growth bet o…
Oracle has moved from an AI underdog to a central infrastructure supplier as OpenAI and Anthropic chase scale. With partner-funded data-center expansion, accelerating RPO and a string of recent commercial wins, Oracle is positioned to capture the revenue and margin upside from the enterprise AI arms race. This trade targets continued re-rating over…
Applied Optoelectronics (AAOI) has moved from speculative turnaround to commercial momentum: multiple hyperscale volume orders for 800G and 1.6T transceivers, a major new Texas manufacturing campus and plans to scale to 500k combined units/month underpin a long-term trade. The valuation is rich and fundamentals show losses and negative free cash fl…
Cybin (CYBN) is a clinical-stage neuropsychiatric company trading at a modest ~$298M market cap. Recent regulatory and policy signals, expanding analyst coverage, and a live Phase II program create an asymmetric risk/reward for a tactical long. We upgrade to a buy and lay out a clear entry at $8.00, a stop at $5.50 and targets at $12.00 (mid) and $…
Travere (TVTX) looks attractively positioned if FILSPARI (sparsentan) captures FSGS market share or becomes an acquisition target. The stock trades at a market cap of roughly $3.58B despite negative earnings, modest free cash flow, and material leverage. This trade idea lays out a clear entry, stop and target with a long-term horizon while flagging…
Advanced Micro Devices (AMD) has rallied into fresh 52-week highs with strong momentum and improving data-center positioning. I see a clear, actionable long setup into $300 over the next 45 trading days, with an entry at $285, a stop at $265 and a $300 target. The thesis leans on accelerating AI demand, improving free cash flow and conservative bal…
Credo's $750M acquisition of DustPhotonics and management guidance for >$500M optical revenue in fiscal 2027 materially changes the company's growth profile. Pairing best-in-class active electrical cables with in-house silicon photonics gives Credo a pathway to multiple new rack-to-rack and rack-to-optic upgrade cycles at hyperscalers. Valuation re…
Southern Copper (SCCO) remains in a constructive uptrend supported by solid cash generation, strong returns and a tight copper market. The setup favors adding exposure on modest weakness with a clear stop and a 180-trading-day target toward prior highs.
Red Cat (RCAT) is carving out a credible niche in multi-domain intelligence, surveillance and reconnaissance (ISR) with recent M&A and partner wins, an early order book for its Black Widow product, and improving commercial traction. The stock is richly valued versus trailing revenue but offers a clear upside path if execution on autonomy and intern…
Coherent has leapt from deep-cyclical lows into a leadership position in photonics and lasers for data center and semiconductor customers. The company carries a stretched valuation (P/E ~340, P/S ~10.4) and negative free cash flow, yet strong partner endorsements, S&P inclusion and bullish technicals open a tactical buying opportunity for disciplin…
Rocket Lab (RKLB) is a tactical buy ahead of the anticipated SpaceX IPO that should lift demand for launch services and sentiment across the sector. The company combines position in launches, a growing $1.9B backlog and Neutron upside with a stretched valuation and execution risk. This trade recommends a mid-term long with strict risk controls and …
Surf Air Mobility (SRFM) trades like a micro-cap with headline risk, but a meaningful commercial launch of SurfOS and a $100M strategic relationship with Palantir create a near-term path to revenue expansion. Market cap sits below $100M while EV is ~$140M and price-to-sales is 0.87x; for patient, risk-aware traders this is a directional long with d…
AEVEX (AVEX) is a newly public defense-tech firm building a full drone and autonomy stack for ISR and tactical missions. The IPO and recent rally put the stock into growth multiple territory, but strong institutional demand, a $3.22B market cap and visible contract leverage create an actionable mid-term long trade with defined risk controls.
We upgrade Xero to a buy for a mid-term swing: an AI partnership plus positive industry survey results create a clear catalyst path for subscription growth and monetization. Entry at $12.50, stop at $10.50, target $16.00 over roughly 45 trading days if execution and uptake track expectations.
Brookfield Corporation pairs hard assets with an emerging insurance and asset-management engine. At a $103.8B market cap and trading near $46.41, the stock offers asymmetric upside if management converts insurance float and AUM into high-margins and carried interest. This trade targets $65 with a $41 stop, sized for a long-term hold (180 trading da…
Albemarle sits at the center of a potential structural shift in lithium demand driven by utility-scale battery energy storage systems (BESS). With capacity discipline, asset sales and targeted reactivations, the company can convert improving lithium pricing into durable margins. This trade targets a mid-term move to $230 while protecting downside w…
Apple’s recent leadership changes look like continuity by another name: experienced insiders, an intact product roadmap and a capital return engine that keeps investors comfortable. This trade idea targets a measured long exposure with defined risk limits — capture upside from product and services momentum while protecting against execution and reg…
First Quantum Minerals (FQVLF) is a large copper producer ($22.5B market cap) trading well above 2025 lows but still below its January highs. A combination of improving copper fundamentals, operational resets, and an active short base creates an asymmetric swing trade. This idea lays out a specific entry, stop and target with horizon and risk contr…
Perma-Pipe (PPIH) has retraced from its 52-week high and is trading at a more attractive entry after strong backlog and Q1 recovery. Fundamentals show improving profitability (trailing EPS $2.10, ROE ~18.8%) and a modest leverage profile. This trade idea presents a measured long with defined entry, stop and target tailored to a mid-term horizon.
American Water Works (AWK) is a high-quality regulated utility trading below prior highs after a period of weak technical momentum and merger uncertainty. With 2026 EPS guidance at $6.02-$6.12, a 7-9% long-term growth target, and an ongoing merger with Essential Utilities plus an accretive acquisition pipeline, the risk/reward at $131.45 is attract…
NAN offers a monthly tax-exempt distribution (annualized yield ~7.58%) and is trading inside a tight 52-week range. Technicals and income make a case for a mid-term long trade with defined entry, stop and target levels.
Zions Bancorporation is showing the building blocks for a 2026 re-rating: rising yields should lift net interest income, recent corporate actions (a $75M repurchase and steady dividend) support per-share cash flow, and the stock trades at a modest P/E and low P/B. We lay out a long trade with entry at $62.00, stop at $57.00 and a primary target of …
Intuitive Machines (LUNR) is trading near $28.41 after a run from a $6.75 52-week low as investor focus shifts from a single lunar mission to recurring cislunar services. The company shows early revenue upside via government and commercial lunar contracts (including a $180.4 million award), strong liquidity per share, but valuation metrics (P/S ~20…
Abbott Laboratories (ABT) is trading near its 52-week low at $93.71 while still generating strong free cash flow and paying a $0.63 quarterly dividend (2.5% yield). A combination of an earnings-guidance reset, acquisition-related dilution fears, and macro volatility pushed the stock lower. Fundamentals—$11.16B in Q1 revenue, solid device and diabet…
